Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 9/20 | 0.35 |
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14267880 | 1.00 | ALDH1A1 (0.36) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL6679145 | 1.00 | ALDH1A1 (0.36) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL7866881 | 0.84 | MAPT (0.31) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL7866883 | 0.84 | MAPT (0.31) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL22314252 | 0.83 | ALDH1A1 (0.36) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL6678561 | 0.83 | ALDH1A1 (0.36) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL6682431 | 0.81 | ALDH1A1 (0.35) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL6682436 | 0.81 | ALDH1A1 (0.35) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL14267879 | 0.75 | MAPT (0.35) | ALDH1A1GAAMAPTMEN1KMT2A | |
| SCHEMBL6679326 | 0.70 | ALDH1A1 (0.35) | ALDH1A1GAAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1033965-B1 | AGENTS AND METHOD FOR PRODUCING SEMI-PERMANENT COLORATIONS OF KERATIN FIBERS | WELLA AG (DE) | 2004-11-24 | — | — | EP | claimed |
| EP-0980236-B1 | COLOURANT AND METHOD FOR PRODUCING TEMPORARY HAIR COLOURS | WELLA AG (DE) | 2003-04-23 | — | — | EP | claimed |
| US-6361571-B1 | USING TAUTOMERIC NONOXIDATIVE DYES AND POLYMETHINE DYES | WELLA AKTIENGESELLSCHAFT (DE) | 2002-03-26 | — | — | US | claimed |
| EP-1033965-A2 | AGENTS AND METHOD FOR PRODUCING SEMI-PERMANENT COLORATIONS OF KERATIN FIBERS | Wella Aktiengesellschaft (DE) | 2000-09-13 | — | — | EP | claimed |
| WO-1999059529-A2 | AGENTS AND METHOD FOR PRODUCING SEMI-PERMANENT COLORATIONS OF KERATIN FIBERS | WELLA AKTIENGESELLSCHAFT (DE) | 1999-11-25 | — | — | WO | claimed |
| US-12569470-B2 | Vasodilator and use thereof | BIORADICAL RESEARCH INSTITUTE CORP. (JP) | 2026-03-10 | — | — | US | disclosed |
| US-20230330066-A1 | Vasodilator and Use Thereof | BIORADICAL RESEARCH INSTITUTE CORP. (JP) | 2023-10-19 | — | — | US | disclosed |
| US-20220110916-A1 | Antioxidant and Use Thereof | BIORADICAL RESEARCH INSTITUTE CORP. (JP) | 2022-04-14 | — | — | US | disclosed |
| US-7955775-B2 | Image-forming method using heat-sensitive transfer system | FUJIFILM CORPORATION (JP) | 2011-06-07 | — | — | US | disclosed |
| US-7955775-B2 | Image-forming method using heat-sensitive transfer system | FUJIFILM CORPORATION (JP) | 2011-06-07 | — | — | US | disclosed |
| US-20070212636-A1 | Image-forming method using heat-sensitive transfer system | FUJIFILM CORPORATION (JP) | 2007-09-13 | — | — | US | disclosed |
| US-20070212636-A1 | Image-forming method using heat-sensitive transfer system | FUJIFILM CORPORATION (JP) | 2007-09-13 | — | — | US | disclosed |
| EP-1033965-B1 | AGENTS AND METHOD FOR PRODUCING SEMI-PERMANENT COLORATIONS OF KERATIN FIBERS | WELLA AG (DE) | 2004-11-24 | — | — | EP | disclosed |
| EP-0980236-B1 | COLOURANT AND METHOD FOR PRODUCING TEMPORARY HAIR COLOURS | WELLA AG (DE) | 2003-04-23 | — | — | EP | disclosed |
| US-6361571-B1 | USING TAUTOMERIC NONOXIDATIVE DYES AND POLYMETHINE DYES | WELLA AKTIENGESELLSCHAFT (DE) | 2002-03-26 | — | — | US | disclosed |
| US-6312478-B1 | TWO COMPONENT KIT; ONE COMPONENT IS A COLORANT COMPRISING A MONOMETHINE OR POLYMETHINE DYE; SECOND COMPONENT CONSISTING OF A DECOLORIZING AGENT | WELLA AKTIENGESELLSCHAFT (DE) | 2001-11-06 | — | — | US | disclosed |
| EP-1033965-A2 | AGENTS AND METHOD FOR PRODUCING SEMI-PERMANENT COLORATIONS OF KERATIN FIBERS | Wella Aktiengesellschaft (DE) | 2000-09-13 | — | — | EP | disclosed |
| EP-0980236-A1 | COLOURANT AND METHOD FOR PRODUCING TEMPORARY HAIR COLOURS | Wella Aktiengesellschaft (DE) | 2000-02-23 | — | — | EP | disclosed |
| WO-1999059529-A2 | AGENTS AND METHOD FOR PRODUCING SEMI-PERMANENT COLORATIONS OF KERATIN FIBERS | WELLA AKTIENGESELLSCHAFT (DE) | 1999-11-25 | — | — | WO | disclosed |
| WO-1999044569-A1 | COLOURANT AND METHOD FOR PRODUCING TEMPORARY HAIR COLOURS | WELLA AKTIENGESELLSCHAFT (DE) | 1999-09-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230330066-A1 | Vasodilator and Use Thereof | NOX4, NOX1, NOX5 | ALDH1A1 466/4885GAA 4371/4885MAPT 4197/4885 |
| US-12569470-B2 | Vasodilator and use thereof | ROS1, NOX3, ADRB3 | ALDH1A1 439/4885GAA 2918/4885MAPT 4759/4885 |
| US-20220110916-A1 | Antioxidant and Use Thereof | GPX1, GPX4, SOD1 | ALDH1A1 137/4885GAA 3447/4885MAPT 4229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.